Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2025-12-25 @ 3:56 AM
NCT ID:
NCT05884502
Eligibility Criteria:
Inclusion Criteria:
1. Those with primary hypercholesterolemia among those whose lesions were confirmed by brain CT or MRI within 48 hours of the onset of ischemic stroke
2. Adults 19 years of age or older
3. Patients who agreed to participate in this study
Exclusion Criteria:
1. Patients scheduled for carotid endarterectomy or stenting, cerebral artery stenting, coronary angioplasty and stenting, or coronary artery bypass surgery within 3 months
2. Patients with malignant tumors that have not been cured
3. Patients who have participated in other drug clinical trials within the last 30 days
4. Patients expected to experience side effects when taking rosuvastatin and ezetimibe
5. Patients who did not consent to participate in this study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT05884502
Study Brief:
Protocol Section:
NCT05884502